Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 385324

Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial)


Včev, Aleksandar; Včeva, A.; Kurbel, S.; Takač, B.; Štimac, Davor; Ivandić, A.; Ostojić, Rajko; Barbir, A.; Horvat, D.; Mihaljević, S.
Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial) // Wiener klinische Wochenschrift, 113 (2001), 23-24; 939-941 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 385324 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial)

Autori
Včev, Aleksandar ; Včeva, A. ; Kurbel, S. ; Takač, B. ; Štimac, Davor ; Ivandić, A. ; Ostojić, Rajko ; Barbir, A. ; Horvat, D. ; Mihaljević, S.

Izvornik
Wiener klinische Wochenschrift (0043-5325) 113 (2001), 23-24; 939-941

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Duodenal ulcer; Helicobacter pylori; Amoxycillin; Clarithromycin

Sažetak
Background: Sucralfate enhances the anti-Helicobacter pylori activity of antimicrobials and has an inhibitory effect on H. pylori. Aim: To evaluate the efficacy and safety of one-week sucralfate-based eradication therapy for H. pylori infection in patients with duodenal ulcers, compared with treatment based on pantoprazole, in a randomized controlled multicenter study. Methods: One hundred and twenty patients with active duodenal ulcers and H. pylori infection were treated with amoxycillin 1 g b.d. plus clarithromycin 500 mg b.d. for the first 7 days. Patients were randomly assigned to receive either sucralfate 1 g t.d.s. for 4 weeks (SAC group ; n = 60) or pantoprazole (PAC group ; n = 60) 40 mg b.d. for the first 7 days and 40 mg o.d. for the next 3 weeks. The patient's H. pylori status was determined by a urease test and histological investigation before the treatment, and again 4 weeks after cessation of all medication. Results: One hundred and eleven patients completed the study. H. pylori infection was eradicated in 76.4% (42/55) of patients in the SAC group (ITT analysis: 70%, 95% CI: 58-80%) vs. 85.7% (48/56) of patients in the PAC group (ITT analysis: 80%, 95% CI: 70-89) (N.S.). All ulcers had healed. There were no significant differences between the two regimens regarding the occurrence of adverse effects. Conclusion: Our study shows that one-week triple therapy with amoxycillin, clarithromycin and either pantoprazole or sucralfate are effective regimens to cure H. pylori infection in patients with duodenal ulcer.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Klinički bolnički centar Rijeka

Profili:

Avatar Url Ante Ivandić (autor)

Avatar Url Aleksandar Včev (autor)

Avatar Url Boris Takač (autor)

Avatar Url Ante Barbir (autor)

Avatar Url Andrijana Včeva (autor)


Citiraj ovu publikaciju:

Včev, Aleksandar; Včeva, A.; Kurbel, S.; Takač, B.; Štimac, Davor; Ivandić, A.; Ostojić, Rajko; Barbir, A.; Horvat, D.; Mihaljević, S.
Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial) // Wiener klinische Wochenschrift, 113 (2001), 23-24; 939-941 (međunarodna recenzija, članak, znanstveni)
Včev, A., Včeva, A., Kurbel, S., Takač, B., Štimac, D., Ivandić, A., Ostojić, R., Barbir, A., Horvat, D. & Mihaljević, S. (2001) Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial). Wiener klinische Wochenschrift, 113 (23-24), 939-941.
@article{article, author = {V\v{c}ev, Aleksandar and V\v{c}eva, A. and Kurbel, S. and Taka\v{c}, B. and \v{S}timac, Davor and Ivandi\'{c}, A. and Ostoji\'{c}, Rajko and Barbir, A. and Horvat, D. and Mihaljevi\'{c}, S.}, year = {2001}, pages = {939-941}, keywords = {Duodenal ulcer, Helicobacter pylori, Amoxycillin, Clarithromycin}, journal = {Wiener klinische Wochenschrift}, volume = {113}, number = {23-24}, issn = {0043-5325}, title = {Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial)}, keyword = {Duodenal ulcer, Helicobacter pylori, Amoxycillin, Clarithromycin} }
@article{article, author = {V\v{c}ev, Aleksandar and V\v{c}eva, A. and Kurbel, S. and Taka\v{c}, B. and \v{S}timac, Davor and Ivandi\'{c}, A. and Ostoji\'{c}, Rajko and Barbir, A. and Horvat, D. and Mihaljevi\'{c}, S.}, year = {2001}, pages = {939-941}, keywords = {Duodenal ulcer, Helicobacter pylori, Amoxycillin, Clarithromycin}, journal = {Wiener klinische Wochenschrift}, volume = {113}, number = {23-24}, issn = {0043-5325}, title = {Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial)}, keyword = {Duodenal ulcer, Helicobacter pylori, Amoxycillin, Clarithromycin} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font